OBINUTUZUMAB for Chronic lymphocytic leukaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 4,557 adverse event reports in the FDA FAERS database where OBINUTUZUMAB was used for Chronic lymphocytic leukaemia.
Most Reported Side Effects for OBINUTUZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 1,584 | 11.2% | 139 | 239 |
| Neutropenia | 1,276 | 9.0% | 112 | 331 |
| Febrile neutropenia | 955 | 6.7% | 91 | 473 |
| Covid-19 | 942 | 6.6% | 263 | 505 |
| Pyrexia | 920 | 6.5% | 122 | 525 |
| Thrombocytopenia | 889 | 6.3% | 77 | 164 |
| Disease progression | 831 | 5.9% | 184 | 75 |
| Infusion related reaction | 789 | 5.6% | 58 | 252 |
| Pneumonia | 662 | 4.7% | 170 | 445 |
| Anaemia | 640 | 4.5% | 53 | 111 |
| Atrial fibrillation | 548 | 3.9% | 36 | 141 |
| Infection | 517 | 3.6% | 69 | 94 |
| Chills | 483 | 3.4% | 15 | 158 |
| Dyspnoea | 478 | 3.4% | 59 | 187 |
| Nausea | 470 | 3.3% | 37 | 166 |
Other Indications for OBINUTUZUMAB
Follicular lymphoma (2,527)
Product used for unknown indication (1,743)
B-cell lymphoma (1,200)
Diffuse large b-cell lymphoma (1,193)
Mantle cell lymphoma (441)
Non-hodgkin's lymphoma (387)
Lymphoma (238)
Marginal zone lymphoma (188)
Chemotherapy (135)
Central nervous system lymphoma (133)
Other Drugs Used for Chronic lymphocytic leukaemia
IBRUTINIB (37,003)
VENETOCLAX (14,194)
RITUXIMAB (7,231)
ACALABRUTINIB (4,515)
IDELALISIB (3,537)
CYCLOPHOSPHAMIDE (3,085)
FLUDARABINE (2,777)
BENDAMUSTINE (2,561)
CHLORAMBUCIL (1,242)
OFATUMUMAB (1,216)